The Expander-2 trial randomly assigned men with BPH symptoms at 23 sites in the US and Canada to receive a temporary nitinol urethral implant, Urocross Expander, or a sham procedure.
Q4 2026 Earnings Call May 24, 2026 7:00 PM EDTCompany ParticipantsPeter Meintjes - Chief Executive OfficerGrant Gibson - ...
A newly released report, which was based on a study that launched in 2024 following a ProPublica investigation, flags nearly ...
It’s increasingly common to see headlines and social media conversations about the rise in colorectal cancer among younger ...
After recent comments from celebs, it may sound like colonoscopy complications are common. But such complications are exceedingly rare, experts say.
For the first time, a blood test has been added to the list of the American Cancer Society’s recommended screenings for ...
More than a decade after removal of an adenoma—a precancerous mass—from the colon, alterations to the gut microbiome and ...
Both robot-assisted simple prostatectomy (RASP) and laser enucleation of the prostate (LEP) are safe and effective surgical options for large-volume benign prostatic hyperplasia (BPH), according to a ...
RICHLAND, Wash. - The Washington Medical Commission has leveled more allegations against Mark Mulholland, MD, an OB/GYN who practiced at Kadlec Medical Center in Richland. The commission started ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results